On 23 February 2026, a young Chinese humanoid robotics company, AI² Robotics (智平方), announced a Series B of over one billion yuan — approximately $144 to $145 million — which lifts its valuation beyond ten billion yuan, or roughly $1.4 billion. The figure is large, but it is not what deserves our attention. What deserves our attention is the list of those who signed the cheque.
For the investors in this round are not, for the most part, venture capital funds. Among them are Baidu’s investment arm, broker Guotai Haitong Securities, fintech services provider Yusys Technologies, tyre manufacturer Sentury Tire — and, above all, CRRC Corp., the Chinese public railway manufacturer. A state-owned industrialist is entering the capital of a robot manufacturer. The question is not how much it has put in, but what it is putting in exchange, and what it expects in return.
The shareholder is also the outlet
The answer is contained in a single sentence, and it is this sentence that changes everything. CRRC is not just bringing capital: it is bringing large-scale industrial environments to test and deploy the robots. Baidu, for its part, is bringing its AI models. In other words, those who are financing the machine are also those who will make it run. The fund that usually invests bets on a future demand it does not control; here, the investor is the demand.
The same press release confirms this without ambiguity: AI² Robotics has secured an order for 1,000 robots over three years from HKC, the world’s third-largest LCD panel manufacturer. Morgan Stanley sees this as the largest individual order in the world in this sector. The purchase order and the funding round are part of the same operation: one capitalises the factory and guarantees in advance who will buy its production. The funds raised will go primarily to the development of the embedded AI model GOVLA and to the expansion of the production capacity of the AlphaBot range — that is, to manufacturing exactly what the shareholders have just pre-ordered.
The quantified objective follows this logic: AI² Robotics aims to produce 10,000 AlphaBot robots in 2026, compared to a capacity of only 1,000 units per year achieved in September 2025. A factor of ten in a few months, backed not by a market to conquer but by an order book already partially filled by the financiers themselves.
And the loop does not stop at production. The CEO of AI² Robotics says he wants to list the company on the stock exchange within one to two years, and the presence of Guotai Haitong Securities among the investors confirms that an IPO is already being prepared. The broker that will value the dossier on the stock exchange has entered the capital upstream: it buys low to sell high an asset whose order book it knows is pre-filled by other shareholders. The industry is financing itself, ordering from itself, and will list itself.
In the West, seven robots are leased on trial
Four days earlier, on 19 February 2026, the West was doing the exact opposite operation — and it is this counter-shot that sharpens the contrast. Agility Robotics and Toyota Motor Manufacturing Canada announced a commercial agreement for the deployment of Digit humanoid robots at the Woodstock plant in Ontario, dedicated to the RAV4. The first commercial deployment of humanoids in automotive production in Canada.
The scope, for its part, has nothing Chinese about it. The agreement covers 7 robots, of which only 3 will be put into service from April 2026; the remaining 4 are conditional on the success of this first wave. And the financial structure is the antithesis of the AI² model: it is a Robots-as-a-Service contract. Toyota subscribes to a subscription including maintenance and software updates, without ever acquiring the robots in ownership. The agreement itself follows a one-year pilot conducted in three phases — development, proof of concept, on-site trial.
On one side, a shareholder-client ordering 1,000 units over three years from a subsidiary it has just capitalised. On the other, an industrialist leasing 3 robots on trial and reserving the right to return the keys. This is not the same market at two speeds: these are two market structures. In the East, industrial and public capital pre-orders the volume it will finance, and will collect it as capital gains on the day of the stock market listing. In the West, the client tests on a lease and keeps the hand on the stop.
From simple to double: the measure of what is sold to oneself
There remains a figure that the week leaves hanging without commenting on it, and which says everything. The projections of humanoid deliveries in China for 2026 diverge from simple to double. The Chinese firm GGII, which puts domestic shipments of 2025 at approximately 18,000 units — a growth of 650% in one year —, estimates 62,500 units in 2026. Morgan Stanley, for its part, projects only 28,000.
This gap is not a quarrel between analysts: it is the accounting translation of the thesis. If demand is pre-ordered by shareholder-deployers like CRRC or HKC, then the high figure describes an order book captured in advance by the industry, independently of any final market. If one waits for real demand, exposed to competition and risk, the low figure holds better. The factor of two between 62,500 and 28,000 is, for all intents and purposes, the measure of what is sold in advance to oneself.
Since autumn, we have seen the demo, the word “autonomous”, the televised scene and the calculations of the number one. This week drops a gear, to the floor of capital. The right question is not whether the Chinese market is moving twice as fast as the West. It is to look at who signs the purchase order — and to note that they have also signed the capital increase cheque. In the West, seven robots are leased on trial. In the East, the shareholder orders a thousand from the subsidiary it has just capitalised.